HitGen Inc - ESG Rating & Company Profile powered by AI
Complete ESG assessment of HitGen Inc can be reached by registering for free. This analysis of HitGen Inc is prepared by All Street Sevva using advanced machine learning. The analysis of HitGen Inc incorporates information from across the internet as well as from available disclosures by HitGen Inc.
HitGen Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.3; made up of an environmental score of 8.0, social score of 4.0 and governance score of 4.0.
5.3
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
645 | Biomm SA | 5.4 | High |
645 | Tiziana Life Sciences PLC | 5.4 | High |
658 | HitGen Inc | 5.3 | High |
658 | Cellmid Ltd | 5.3 | High |
658 | Bio-Techne Corp | 5.3 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
Frequently Asked Questions
Does HitGen Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes HitGen Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes HitGen Inc report the average age of the workforce?
Sign up for free to unlockDoes HitGen Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes HitGen Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes HitGen Inc disclose cybersecurity risks?
Sign up for free to unlockDoes HitGen Inc offer flexible work?
Sign up for free to unlockDoes HitGen Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes HitGen Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes HitGen Inc conduct supply chain audits?
Sign up for free to unlockDoes HitGen Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes HitGen Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes HitGen Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes HitGen Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes HitGen Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes HitGen Inc disclose water use targets?
Sign up for free to unlockDoes HitGen Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid HitGen Inc have a product recall in the last two years?
Sign up for free to unlockDoes HitGen Inc disclose incidents of discrimination?
Sign up for free to unlockDoes HitGen Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas HitGen Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes HitGen Inc disclose parental leave metrics?
Sign up for free to unlockDoes HitGen Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes HitGen Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes HitGen Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes HitGen Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes HitGen Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes HitGen Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs HitGen Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes HitGen Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes HitGen Inc disclose its waste policy?
Sign up for free to unlockDoes HitGen Inc report according to TCFD requirements?
Sign up for free to unlockDoes HitGen Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes HitGen Inc disclose energy use targets?
Sign up for free to unlockDoes HitGen Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes HitGen Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for HitGen Inc
These potential risks are based on the size, segment and geographies of the company.
HitGen Inc. operates a platform for early-stage drug discovery research focusing on DNA encoded chemical libraries (DELs). Its DELs include encoded syntheses for diverse, drug-likesmall molecule, and macrocycle compounds. The company has internal projects in research, with Phase I, PCC generation, and in lead generation stages that focus on oncology, CVD, inflammation/respiratory, metabolism, and ophthalmology therapeutic areas. HitGen Inc. has a drug discovery research collaboration with Gilead Sciences, Galapagos NV, Kymera Therapeutics, Inc., and Morphic Therapeutic to identify potential small molecule leads; a strategic partnership with Oncodesign Société Anonyme for the identification and progression of new chemical entities; and an agreement with Lipigon Pharmaceuticals AB to include a second novel target, as well as a research collaboration agreement with Dorian Therapeutics, Inc. to discover compounds that bind to certain targets that are of interest to Dorian. The company also has a strategic alliance with Cambridge Molecular Technologies Ltd. to introduce DeepDELve 2 " Cambridge Molecular's DEL-specific deep learning system as an addition to HitGen's DEL discovery platform with approximately 1 trillion drug-like small molecules. HitGen Inc. was founded in 2012 and is based in Chengdu, China.